Water-soluble ureidomustine (BO-1055) potently suppresses orthotopic 22Rv/HL2 prostate tumor xenografts: Early preclinical studies Meeting Abstract
| Authors: | Su, T. L.; Chen, Y. R.; Shieh, J.H.; Tsai, T. H.; Moore, M. A. S.; Lee, T. C. |
| Abstract Title: | Water-soluble ureidomustine (BO-1055) potently suppresses orthotopic 22Rv/HL2 prostate tumor xenografts: Early preclinical studies |
| Meeting Title: | 105th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 74 |
| Issue: | 19 Suppl. |
| Meeting Dates: | 2014 Apr 5-9 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2014-10-01 |
| Language: | English |
| ACCESSION: | WOS:000349906905283 |
| DOI: | 10.1158/1538-7445.am2014-823 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 823 -- 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 05-09, 2014 -- San Diego, CA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
